Epstein Secrets

ve and quantitative information about investment processes ■ Regular meetings with investors ■ Investments by partners and employees comprise 7% of Och-Ziff's AUMI ■ Och-Ziff's partners receive a substantial majority of their compensation from distributions tied to profitability As of September I. 2015 u

d. OCH-ZIFF CAPITAL MANAGEMENT GROUP 7 EFTA00601465 ft OCH-ZI FF ICS Global Team CAPITAL MANAGEMENT GROUP ICS Investment Committee — U.S. David Windreich—EMD, Head of U.S. and European Investing, Member of Partner Management Committee Harold Kelly— EMD, Head of Global Convertible and Derivative Arbitr

Mount Sinai Medical Center. Harold Kelly is Head of Global Convertible and Derivative Arbitrage and Risk Management for Och-Ziff and is a member of Och-Ziff's Partner Management Committee. Mr. Kelly is also an Executive Managing Director. Prior to joining Och-Ziff in 1995, Mr. Kelly spent seven years tradi

OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is a

Mount Sinai Medical Center. Harold Kelly is Head of Global Convertible and Derivative Arbitrage and Risk Management for Och-Ziff and is a member of Och-Ziff's Partner Management Committee. Mr. Kelly is also an Executive Managing Director. Prior to joining Och-Ziff in 1995, Mr. Kelly spent seven years tradi

OCH-ZIFF Och-Ziff Professional Biographies CAPITAL MANAGEMENT GROUP ICS Investment Committee David Windreich is Head of U.S. and European Investing for Och-Ziff and is a member of OZM's Board of Directors and Partner Management Committee. Mr. Windreich is a